Insights
TGA announces final CBD down-scheduling
Registered CBD products to be dispensed over-the-counter without a prescription
Dec 2020
Good Manufacturing Practices licence granted
Company news
27 Oct 2020
Little Green Pharma was recently granted a Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence for its recently commissioned manufacturing facility in Western Australia. This license means:
- LGP will now be able to produce medicinal cannabis flower products
- LGP has the benefit of enhanced manufacturing capacity in addition to our existing pharmaceutical manufacturer
- strong supply reliability for patients
The GMP licencing of the Company’s manufacturing facility is the culmination of a two-year regulatory strategy.
Little Green Pharma now holds over 20 State and Federal operating authorisations, allowing it to operate a fully in-house and vertically-integrated cannabis cultivation, production, manufacturing, and wholesaling supply chain, capable of supplying various LGP branded medicinal cannabis products into Australian and international markets.
The manufacturing facility was constructed with funding support from the West Australian Government and represents a regional manufacturing success story for South West Western Australia.
You might also be interested in
Insights
LGP Signs Exclusive Oils Distribution Agreement with German Distributor AMP
LGP signs three-year distribution agreement with AMP for the distribution of LGP-branded cannabis oil medicines in Germany
Jan 2022
